戴德梁行：2024中国生命科学政策导向及产业园研究报告（英文版）（38页）.pdf

1、2024.6Greater China ResearchDIAGNOSING THE MARKET:THE CHINESE MAINLAND LIFE SCIENCES SECTORCONTENTS040506090821353638Executive SummaryIntroductionLife Sciences PolicyLife Sciences Industry Macro DriversLife Sciences Industry MovesLife Sciences Real Estate Market and OutlookKey TakeawaysBusiness Cont

2、actsResearch Contacts2 CUSHMAN&WAK E F IE L DDiagnosing the Market:The Chinese Mainland Life Sciences Sector 3The life sciences industry is continuing to evolve.The industrys development is being supported by a number of factors.Of the more important elements,four include policy,industry growth,popu

3、lation demographic dynamics,and the level of innovation.PolicyOver time,a number of important life sciences-related policies have been authorised and implemented in China.One of the more important ones is the 14th Five-Year Plan,which has promoted a solid public health system,the expansion of nation

4、al healthcare insurance,and the further development of traditional Chinese medicine(TCM).Life Sciences Industry Growth Today,when making a global comparison,Chinas biopharmaceutical industry maturity level,in terms of genetic engineering and innovative medicine research and development(R&D),has reac

5、hed or even surpassed the level seen in many other mature-market countries.Whats more,according to estimates from Frost&Sullivan,the total healthcare expenditure in China reached RMB7.6 trillion in 2021 and is expected to achieve and maintain a stable growth in the future at a CAGR of 9.5%to reach R

6、MB13.0 trillion in 2027.Population DemographicsPopulation demographics in China are moving in a favourable direction for life sciences enterprises.As people age,more often than not,an increase in the level of individual healthcare is required.According to Eastspring China,by 2035,Chinas aged populat